<DOC>
	<DOC>NCT01851109</DOC>
	<brief_summary>The primary purpose of this study is to evaluate the effect of systematic identification and genetic counseling referral on rates of bilateral salpingo-oophorectomy (surgery to remove both fallopian tubes and ovaries) in women having mammograms at Swedish Medical Center in Seattle, WA.</brief_summary>
	<brief_title>Prevention of Ovarian Cancer in Women Participating in Mammography</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
	<criteria>Prior mammogram at Swedish Medical Center Willing and able to provide informed consent, primary physician information, and complete study questionnaires Must meet at least ONE of the following criteria: personal history of breast cancer diagnosed before age 50 personal history of bilateral breast cancer at any age 1 or more first degree relatives with breast cancer diagnosed before age 50 3 or more first or second degree relatives with breast cancer at any age 2 second degree relatives with breast cancer diagnosed before age 50 A male relative with breast cancer at any age Ashkenazi Jewish with any family history of breast or ovarian cancer 1 first or second degree relative with ovarian cancer AND 1 first or second degree relative with breast cancer at any age 2 first degree relatives with ovarian cancer or 2 second degree relatives with ovarian cancer or 1 first and 1 second degree relative with ovarian cancer. A first degree relative with both breast and ovarian cancer (2 primaries in the same person) Personal history of positive genetic test result for any of the following genes: BRCA1, BRCA2, HNPCC, or P53 Family history of a positive genetic test result for any of the following genes: BRCA1, BRCA2 or HNPCC Previous diagnosis of ovarian cancer Prior bilateralsalpingo oophorectomy Had a negative genetic test result for a known family genetic mutation</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ovarian cancer</keyword>
	<keyword>prevention</keyword>
	<keyword>prophylactic surgery</keyword>
	<keyword>risk</keyword>
	<keyword>biomarkers</keyword>
	<keyword>screening</keyword>
	<keyword>symptoms</keyword>
</DOC>